You are here

  • Home
  • Archive
  • Volume 8, Issue 7
  • The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries

Article info

Article menu
Original research
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries

Authors

  • Allison Portnoy Department of Global Health, Boston University School of Public Health, Boston, MA, USACenter for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA PubMed articlesGoogle scholar articles
  • Rebecca A Clark Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UKTB Modelling Group, London School of Hygiene & Tropical Medicine, London, UKCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK PubMed articlesGoogle scholar articles
  • Chathika K Weerasuriya Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UKTB Modelling Group, London School of Hygiene & Tropical Medicine, London, UKCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK PubMed articlesGoogle scholar articles
  • Christinah Mukandavire Coalition for Epidemic Preparedness Innovations, London, UK PubMed articlesGoogle scholar articles
  • Matthew Quaife Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UKTB Modelling Group, London School of Hygiene & Tropical Medicine, London, UKCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK PubMed articlesGoogle scholar articles
  • Roel Bakker Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UKTB Modelling Group, London School of Hygiene & Tropical Medicine, London, UKCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UKKNCV Tuberculosis Foundation, Den Haag, The Netherlands PubMed articlesGoogle scholar articles
  • Inés Garcia Baena Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Nebiat Gebreselassie Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Matteo Zignol Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Mark Jit Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UKCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UKSchool of Public Health, The University of Hong Kong, Hong Kong SAR, People's Republic of China PubMed articlesGoogle scholar articles
  • Richard G White Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UKTB Modelling Group, London School of Hygiene & Tropical Medicine, London, UKCentre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropica Medicine, London, UK PubMed articlesGoogle scholar articles
  • Nicolas A Menzies Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USADepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Allison Portnoy; aportnoy{at}bu.edu
View Full Text

Citation

Portnoy A, Clark RA, Weerasuriya CK, et al
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
BMJ Global Health 2023;8:e012466.

Publication history

  • Received March 31, 2023
  • Accepted June 10, 2023
  • First published July 12, 2023.
Online issue publication 
October 18, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© World Health Organization 2023. Licensee BMJ. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (CC BY 3.0 IGO), which permits use, distribution,and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.